“…This may be due to the fact that transient transfection is still commonly regarded as a nonscaleable technology. However, it should be noted that in recent years transient transfection of suspension-growing cells has emerged as a powerful technology for the large-scale production of biopharmaceuticals (Durocher et al, 2002;Geisse and Henke 2005;Muller et al, 2005;Pham et al, 2003Pham et al, , 2005Rosser et al, 2005;Sun et al, 2006). Additionally, this technology has recently shown great potential for the large-scale manufacturing of adeno-associated viral vectors (Park et al, 2006;Reed et al, 2006).…”